Form 4: Phio Pharmaceuticals CEO Buys Shares
Insider Transaction (Form 4)
Robert J Bitterman, Chairman, Pres. & CEO and a Director of Phio Pharmaceuticals Corp., purchased 2,000 shares of common stock on September 22, 2026 for $1.03 per share.
Summary
- Open-market purchase: acquired 2,000 Common Stock, $.0001 par value at $1.03 ($2,058) on September 22, 2026; holds 364,871 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $2,058, committing personal capital to the stock.
Insider Transactions
Robert J Bitterman — Director, Officer (Chairman, Pres. & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Open-market purchase | Common Stock, $.0001 par value | 2,000 | $1 | $2.1K | 364,871 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Open-market purchase (2,000 shares) |
Keywords
insider transaction, Form 4, PHIO, Phio Pharmaceuticals Corp., bullish, Robert J Bitterman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.